Rolph Timothy sold AKRO
September 8, 2025 · Form 4 insider transaction
Rolph Timothy sold 34 shares of Akero Therapeutics, Inc. at $44.88 per share, a transaction worth $1.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
34
Price
$44.88
Total value
$1.5K
InsiderRolph Timothy
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 8, 2025
Filing dateSeptember 10, 2025
Shares owned after167,124
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated August 12, 2024, previously adopted by the Reporting Person.